Outcome of Board Meeting dated 06th August, 2025 for Allotment of 88,08,000 Warrants
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shelter Pharma Ltd's board, meeting on August 6, 2025, approved the allotment of 88,08,000 convertible warrants at Rs. 42.25 per warrant, aggregating to Rs. 37.21 crore. The warrants were issued on a preferential basis to 36 allottees, including promoters, promoter group members, and non-promoter investors. The company has already received Rs. 9.30 crore as the upfront 25% subscription amount. Each warrant is convertible into one equity share of Rs. 10 face value within 18 months, upon payment of the remaining 75%. Promoter and promoter group members received about 30,03,000 warrants, while non-promoter allottees received the remaining 58,05,000 warrants.
This preferential warrant issue will dilute existing shareholders by up to 88,08,000 shares if all warrants are converted within 18 months. However, the participation by promoters signals insider confidence, and the Rs. 37.21 crore potential inflow could strengthen the company's capital base.